Christophe Ghysel

Brugge, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial.

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial.

Journal: Frontiers in oncology

Published: July 03, 2026

Clinical trial protocol of PODRACING: A randomized controlled trial evaluating 3D perfusion zone models for selective arterial clamping during robot-assisted partial nephrectomy.

Clinical trial protocol of PODRACING: A randomized controlled trial evaluating 3D perfusion zone models for selective arterial clamping during robot-assisted partial nephrectomy.

Journal: BJUI compass

Published: January 08, 2026

Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial.

Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial.

Journal: Frontiers in oncology

Published: December 14, 2025

Robotic-assisted resection of parametrial endometriosis with ureterolysis of a medially distorted ureter using indocyanine green and near-infrared fluorescence.

Robotic-assisted resection of parametrial endometriosis with ureterolysis of a medially distorted ureter using indocyanine green and near-infrared fluorescence.

Journal: Journal of surgical case reports

Published: October 18, 2025

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial.

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial.

Journal: European urology oncology

Published: January 22, 2025

Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

Author Correction: Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

Journal: Nature medicine

Published: August 28, 2024

Androgen deprivation therapy in advanced prostate cancer: insights from a real-world patient survey on health-related quality of life and information and communication sources.

Androgen deprivation therapy in advanced prostate cancer: insights from a real-world patient survey on health-related quality of life and information and communication sources.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: June 05, 2024

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial.

Journal: Nature medicine

Published: January 13, 2024

Fluorescence guidance during robotic resection of bladder wall endometriosis: case report and technique.

Fluorescence guidance during robotic resection of bladder wall endometriosis: case report and technique.

Journal: Journal of surgical case reports

Published: September 19, 2023

Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal.

Primary leiomyosarcoma of the uterine cervix: an unusual case and critical appraisal.

Journal: Journal of surgical case reports

Published: June 28, 2023

Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis.

Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis.

Journal: Acta clinica Belgica

Published: November 18, 2021

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer.

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer.

Journal: Cancers

Published: February 11, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026